Blair William & CO Adaptive Biotechnologies Corp Transaction History

Blair William & CO

$33.4 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$3.46 - $5.33 $169,591 - $261,249	-49,015 Reduced 76.99%	14,649 $71,000
Q3 2023 Nov 09, 2023	SELL	$5.07 - $8.44 $67,938 - $113,096	-13,400 Reduced 17.39%	63,664 $346,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $11,142 - $15,803	-1,800 Reduced 2.28%	77,064 $517,000
Q1 2023 May 12, 2023	BUY	$7.8 - $10.11 $59,420 - $77,017	7,618 Added 10.69%	78,864 $696,000
Q4 2022 Feb 10, 2023	SELL	$6.26 - $9.34 $33,084 - $49,361	-5,285 Reduced 6.91%	71,246 $544,000
Q3 2022 Nov 09, 2022	BUY	$6.5 - $12.67 $18,720 - $36,489	2,880 Added 3.91%	76,531 $545,000
Q2 2022 Aug 10, 2022	SELL	$6.4 - $14.73 $497,664 - $1.15 Million	-77,760 Reduced 51.36%	73,651 $596,000
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $174,317 - $497,802	-17,225 Reduced 10.21%	151,411 $2.1 Million
Q4 2021 Feb 14, 2022	SELL	$25.17 - $36.85 $2.13 Million - $3.12 Million	-84,607 Reduced 33.41%	168,636 $4.73 Million
Q3 2021 Nov 12, 2021	SELL	$30.02 - $39.87 $771,994 - $1.03 Million	-25,716 Reduced 9.22%	253,243 $8.61 Million
Q2 2021 Aug 12, 2021	SELL	$32.22 - $44.59 $264,977 - $366,708	-8,224 Reduced 2.86%	278,959 $11.4 Million
Q1 2021 May 13, 2021	SELL	$37.26 - $67.74 $5.95 Million - $10.8 Million	-159,770 Reduced 35.75%	287,183 $11.6 Million
Q4 2020 Feb 09, 2021	BUY	$45.01 - $65.47 $763,144 - $1.11 Million	16,955 Added 3.94%	446,953 $26.4 Million
Q3 2020 Nov 06, 2020	BUY	$35.79 - $48.81 $8.78 Million - $12 Million	245,355 Added 132.88%	429,998 $20.9 Million
Q2 2020 Aug 12, 2020	BUY	$24.95 - $48.38 $1.67 Million - $3.23 Million	66,745 Added 56.61%	184,643 $8.93 Million
Q1 2020 May 11, 2020	SELL	$16.96 - $34.16 $1.8 Million - $3.62 Million	-106,072 Reduced 47.36%	117,898 $3.28 Million
Q4 2019 Feb 13, 2020	BUY	$24.56 - $32.8 $2.65 Million - $3.54 Million	107,958 Added 93.06%	223,970 $6.7 Million
Q3 2019 Nov 12, 2019	BUY	$30.31 - $53.51 $3.52 Million - $6.21 Million	116,012 New	116,012 $3.59 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$178 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$85.5 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$69.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$68.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$63.2 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account